5-10236506-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_199133.4(ATPSCKMT):​c.416C>T​(p.Ala139Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

ATPSCKMT
NM_199133.4 missense

Scores

1
1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.72
Variant links:
Genes affected
ATPSCKMT (HGNC:27029): (ATP synthase c subunit lysine N-methyltransferase) Enables protein-lysine N-methyltransferase activity. Involved in peptidyl-lysine trimethylation; positive regulation of sensory perception of pain; and regulation of proton transport. Located in mitochondrial crista. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATPSCKMTNM_199133.4 linkc.416C>T p.Ala139Val missense_variant Exon 3 of 5 ENST00000511437.6 NP_954584.2 Q6P4H8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATPSCKMTENST00000511437.6 linkc.416C>T p.Ala139Val missense_variant Exon 3 of 5 1 NM_199133.4 ENSP00000422338.1 Q6P4H8-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Nov 13, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.416C>T (p.A139V) alteration is located in exon 3 (coding exon 3) of the FAM173B gene. This alteration results from a C to T substitution at nucleotide position 416, causing the alanine (A) at amino acid position 139 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.48
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.012
T;.
Eigen
Benign
-0.096
Eigen_PC
Benign
-0.0098
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.86
D;D
M_CAP
Benign
0.0061
T
MetaRNN
Benign
0.18
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.88
L;L
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-2.2
N;N
REVEL
Benign
0.17
Sift
Benign
0.13
T;D
Sift4G
Benign
0.48
T;T
Polyphen
0.57
P;.
Vest4
0.44
MutPred
0.46
Gain of methylation at K140 (P = 0.0367);Gain of methylation at K140 (P = 0.0367);
MVP
0.17
MPC
0.36
ClinPred
0.76
D
GERP RS
4.4
Varity_R
0.063
gMVP
0.52

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.24
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.24
Position offset: 16

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr5-10236618; API